Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Bivalirudin manufacturer?Mebendazole ingredients?Combivent inhaler hfc 152a patents?Brenzavvy discontinuation?
See the DrugPatentWatch profile for zaltrap
No. Zaltrap is not a biosimilar of aflibercept. It is a brand-name biologic product that contains ziv-aflibercept, which is a specific form of the aflibercept fusion protein. [1]
Aflibercept is commonly associated with the active biologic used in oncology, and ziv-aflibercept is the version marketed as Zaltrap. Biosimilars are separate products designed to be highly similar to an already approved reference biologic, and they must be approved for that biosimilar indication. The information provided here does not indicate that Zaltrap is approved as a biosimilar to aflibercept. [1]
To determine whether something is a biosimilar, check whether the product is labeled as “biosimilar” or references a specific reference product. Zaltrap is identified as ziv-aflibercept, not as a biosimilar. [1] Sources 1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125148s121lbl.pdf
Other Questions About Zaltrap :